HW
ALPN

Hancock Whitney’s Alpine Immune Sciences Inc ALPN Stock Holding History

Hancock Whitney’s Portfolio ALPN Stock Details ALPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-18,721
Closed -$168K – 826
2021
Q2 		$168K Buy
18,721
+7,249
+63% +$78.8K 0.01% 778
2021
Q1 		$122K Hold
11,472
– – ﹤0.01% 750
2020
Q4 		$145K Hold
11,472
– – ﹤0.01% 756
2020
Q3 		$101K Buy
+11,472
New +$105K ﹤0.01% 757

Other funds holding ALPN

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Hancock Whitney's ALPN Position: Q3 2021 in Review

Hancock Whitney sold out of Alpine Immune Sciences Inc (ALPN) in Q3 2021, closing a stake of 18,721 shares — an estimated $168K sold.

Hancock Whitney first reported a position in ALPN in Q3 2020 and held it in 4 quarters. The position peaked at $168K in Q2 2021. 44 funds tracked by Wall St. Rank hold ALPN as of Q3 2021.

  • Hancock Whitney reported no remaining Alpine Immune Sciences Inc position as of Q3 2021 after selling out during the quarter.
  • Hancock Whitney sold 18,721 Alpine Immune Sciences Inc shares in Q3 2021, an estimated $168K.
  • Hancock Whitney first reported a position in Alpine Immune Sciences Inc in Q3 2020 and held it in 4 quarters.
  • Hancock Whitney's Alpine Immune Sciences Inc position peaked at $168K in Q2 2021.
  • 44 funds tracked by Wall St. Rank held Alpine Immune Sciences Inc as of Q3 2021.

Based on Hancock Whitney's 13F filing for Q3 2021, filed 4 Nov 2021.